The Neuropsychology of Migraine

Disease-a-Month

Volumn 53, Issue 3, 2007, Pages 156-161

  Ravishankar, Nandini ^a   Demakis, George J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; MAGNESIUM; SUBSTANCE P; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; CLINICAL FEATURE; COGNITIVE DEFECT; DEPRESSION; HUMAN; LONG TERM CARE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROLOGIC DISEASE; NEUROPSYCHOLOGY; PATHOPHYSIOLOGY; REVIEW; SPATIAL MEMORY; VERBAL MEMORY;

COGNITION; HUMANS; MIGRAINE DISORDERS; NEUROPSYCHOLOGY; SEROTONIN AGONISTS; SEVERITY OF ILLNESS INDEX;

EID: 34249740322     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2007.04.006     Document Type: Review

References (15)

1. Le Pira F., Zappala G., Guiffrida S., et al. Memory disturbances in migraine with and without aura: a strategy problem?. Cephalalgia 20 (2000) 475-478
2. Breslau N., and Davis G.C. Migraine, major depression and panic disorder: a prospective epidemiological study of young adults. Cephalalgia 12 (1992) 85-87
3. Stewart W.F., Lipton R.B., Whyte J., et al. An international study to assess the reliability of the Migraine Disability Assessment Score (MIDAS). Neurology 53 (1999) 988-994
4. The International Classification of Headache Disorders (2nd ed). Cephalalgia 24 (2004) 24-27
5. Lezak M. Clinical Neuropsychology. (4th ed.) (2004), Oxford University Press, New York, NY
6. Graham J.R., and Wolff H.G. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39 (1938) 737-763
7. Goadsby P.J., and Olesen J. Diagnosis and management of migraine. Br Med J 312 (1996) 1279-1283
8. Moskowitz M.A. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43 (1993) S16-S20
9. Derman H.S. Headaches: diagnosis and treatment. Current Neurol 14 (1994) 179-206
10. Calandre E.P., Bembibre J., Arnedo M.L., et al. Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness. Cephalalgia 22 (2002) 291-302
11. Waldie K.E., Hausmann M., Milne B.J., et al. Migraine and cognitive function: a life course study. Neurology 59 (2002) 904-908
12. Meyer J.S., Thornby J., Crawford K., et al. Reversible cognitive decline accompanies migraine and cluster headaches. Headache 40 (2000) 638-646
13. Hooker W.D., and Raskin N.H. Neuropsychologic alterations in common and classic migraine. Arch Neurol 43 (1986) 709-712
14. Lawson W. Depression and migraine. Psychol Today 36 (2000) 24
15. Breslau N., Davis G.C., Schultz L.R., et al. Migraine and major depression: a longitudinal study. Headache 34 (1994) 387